Inventor · disambiguated record
Charles Joseph Eyermann
Also filed as: EYERMANN CHARLES · EYERMANN CHARLES J · EYERMANN CHARLES JOSEPH
11 granted patents·6 pending applications·305 citations·filing 1993–2023
92Inventor score
Files withASTRAZENECA AB4DU PONT MERCK PHARMA4THESEUS PHARMACEUTICALS INC3ARIAD PHARMA INC2BREAULT GLORIA2
Top patents by PatentIndex Score
17 records- 0195US5523302AAromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1993·Granted Jun 4, 1996·59 cites·7 claims
- 0294US7875715B2Compounds for the treatment of multi-drug resistant bacterial infectionsASTRAZENECA AB·Filed 2006·Granted Jan 25, 2011·13 cites·1 claims
- 0393US5811422ASubstituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Sep 22, 1998·108 cites·21 claims
- 0485US8124602B2Compounds for the treatment of multi-drug resistant bacterial infectionsBREAULT GLORIA·Filed 2010·Granted Feb 28, 2012·11 cites·4 claims
- 0584US6482852B2Bicyclic signal transduction inhibitors, compositions containing them & uses thereofARIAD PHARMA INC·Filed 2001·Granted Nov 19, 2002·20 cites·81 claims
- 0683US6573295B2Bicyclic signal transduction inhibitors, compositions containing them & uses thereofARIAD PHARMA INC·Filed 2001·Granted Jun 3, 2003·17 cites·81 claims
- 0782US5610294ASubstituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitorsDU PONT MERCK PHARMA·Filed 1994·Granted Mar 11, 1997·40 cites·20 claims
- 0881US7371757B2Fused heterocycles as inhibitors of glutamate racemase(MURI)ASTRAZENECA AB·Filed 2004·Granted May 13, 2008·28 cites·17 claims
- 0966US2024150375A1Macrocyclic compounds and uses thereofTHESEUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1064US5739163AAromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1996·Granted Apr 14, 1998·8 cites·17 claims
- 1159US2024199614A1Macrocyclic egfr inhibitors for the treatment of cancerTHESEUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1254US2023148005A1Macrocyclic compounds and uses thereofTHESEUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1354US2012108577A1Compounds for the treatment of multi-drug resistant bacterial infectionsBREAULT GLORIA·Filed 2012·Application pending·0 cites
- 1443US2009209022A1Crystal Structure of Ump Kinase and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1540US2007275954A1Novel Fused Heterocycles and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1637US6503898B1Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Jan 7, 2003·1 cites·2 claims
- 1731USRE37781ESubstituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitorsDU PONT PHARM CO·Filed 1999·Granted Jul 2, 2002·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Charles Joseph Eyermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →